Helixmith Co., Ltd.

This trial aimed to test a gene therapy for X-linked chronic granulomatous disease, a condition where the immune system cannot fight certain infections. The treatment involved taking the patient's own stem cells, adding a working copy of the defective gene, and returning them to …

This study was designed to test the safety of a gene therapy called VM202 in people with chronic refractory myocardial ischemia—severe chest pain that doesn't improve with standard treatments. The therapy would be injected directly into the heart via a catheter. However, the tria…

This study aimed to test a gene therapy called VM202RY in people who recently had a heart attack. The treatment was injected directly into the heart muscle to help it heal and improve pumping strength. However, the trial was withdrawn before enrolling any participants, so no data…

This study was designed to test whether PG201, a botanical drug, could reduce pain and improve function in people with knee osteoarthritis. It planned to enroll Korean adults aged 40 to 75 and compare two doses of PG201 against a placebo over 8 weeks. However, the trial was withd…

This study planned to test TADIOS, a blend of three herbs used in traditional Asian medicine, as an add-on treatment for adults hospitalized with mild to moderate COVID-19. Participants would have received TADIOS or a placebo for up to 10 days. The goal was to see if TADIOS could…